ArticleBiomedicines2026

Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Advanced Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis.

Sarina Ailawadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.